Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Povidone-Iodine 5% eye dps 0.4ml unit dose preservative free
1108020AHAAABAB
|
Povidone-Iodine (Eye) | Povidone iodine | Eye | 20 |
|
Minims povidone iodine 5% eye drops 0.4ml unit dose
1108020AHBBABAB
|
Minims povidone-iodine | Povidone iodine | Eye | 17 |
|
Betadine 10% vaginal gel
0702020V0BBABAB
|
Betadine (Vaginal) | Povidone iodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Betadine 200mg vaginal pessaries
0702020V0BBAAAA
|
Betadine (Vaginal) | Povidone iodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Betadine VC Kit 10% solution
0702020V0BBACAC
|
Betadine (Vaginal) | Povidone iodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Minims povidone iodine 5% eye drops 0.5ml unit dose
1108020AHBBAAAA
|
Minims povidone-iodine | Povidone iodine | Eye | No data available |
|
Povidone-Iodine 10% vaginal cleansing solution
0702020V0AAACAC
|
Povidone-Iodine (Vaginal) | Povidone iodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Povidone-Iodine 10% vaginal gel
0702020V0AAABAB
|
Povidone-Iodine (Vaginal) | Povidone iodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Povidone-Iodine 200mg pessaries
0702020V0AAAAAA
|
Povidone-Iodine (Vaginal) | Povidone iodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Povidone-Iodine 5% eye drops preservative free
1108020AHAAAAAA
|
Povidone-Iodine (Eye) | Povidone iodine | Eye | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.